Western Michigan University Homer Stryker M.D. School of Medicine, 300 Portage Street, Kalamazoo, MI 49007, USA; David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave., 90095‑1688, CHS 37‑121, Los Angeles, CA, USA.
David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave., 90095‑1688, CHS 37‑121, Los Angeles, CA, USA.
Int J Infect Dis. 2021 Mar;104:27-33. doi: 10.1016/j.ijid.2020.12.076. Epub 2021 Jan 2.
Rates of maternal syphilis have increased five-fold in Brazil in the past decade. While penicillin remains the only appropriate treatment for maternal syphilis, we hypothesized that low non-treponemal titers (<1:16) may lead to reduced penicillin treatment in Brazil.
Using Brazilian Ministry of Health data on women diagnosed with maternal syphilis between January 1, 2010, and December 31, 2018, we conducted a random-effects logistic regression model with a cluster correction at the state level to evaluate predictive factors of penicillin treatment.
We observed yearly increases in cases of pregnant women with syphilis from 2010 to 2018. There was significant variation by state: 52,451 cases were reported in São Paulo, followed by 26,838 in Rio de Janeiro. Among 215,937 cases of maternal syphilis, 91·3% received penicillin. In the random-effects model, a non-treponemal titer ≥1:16 was associated with 1·44 higher odds of receiving penicillin (95% confidence interval [CI]: 1·391·48), and prenatal care was associated with a 2·12 increased odds of receiving penicillin (95% CI: 2·022·21). Although there is an association between the absence of prenatal care and inadequate treatment for syphilis, 83·2% of women in this cohort who did not receive penicillin were engaged in prenatal care.
Providers may inappropriately exclude low non-treponemal titers and thereby fail to use penicillin treatment in maternal syphilis. While the cause of the maternal syphilis epidemic in Brazil is multifactorial, we believe our findings can be used to develop targeted interventions throughout Brazil as well as shape public health initiatives globally.
在过去十年中,巴西的梅毒产妇发病率增加了五倍。虽然青霉素仍然是治疗梅毒产妇的唯一适当方法,但我们假设低非梅毒螺旋体滴度(<1:16)可能导致巴西减少青霉素治疗。
利用巴西卫生部 2010 年 1 月 1 日至 2018 年 12 月 31 日期间诊断为梅毒产妇的数据,我们采用具有州级聚类校正的随机效应逻辑回归模型,评估青霉素治疗的预测因素。
我们观察到 2010 年至 2018 年期间患有梅毒的孕妇病例逐年增加。各州之间存在显著差异:圣保罗报告了 52451 例,里约热内卢报告了 26838 例。在 215937 例梅毒产妇中,91.3%接受了青霉素治疗。在随机效应模型中,非梅毒螺旋体滴度≥1:16 与接受青霉素治疗的几率增加 1.44 倍(95%可信区间:1.391.48)相关,产前保健与接受青霉素治疗的几率增加 2.12 倍(95%可信区间:2.022.21)相关。尽管缺乏产前保健与梅毒治疗不足之间存在关联,但在未接受青霉素治疗的本队列中,83.2%的女性接受了产前保健。
提供者可能不恰当地排除了低非梅毒螺旋体滴度,从而未能在梅毒产妇中使用青霉素治疗。虽然巴西梅毒流行的原因是多因素的,但我们认为我们的发现可以用于在巴西各地制定有针对性的干预措施,并为全球公共卫生倡议提供参考。